NextPlat Corp. today announced that its ClearMetrX subsidiary has commenced late-stage development of ClearMetrX 4.0, the next generation of its proprietary healthcare data analytics and reporting software. This enhanced software suite will feature a full range of artificial intelligence (AI)-enhanced capabilities.
ClearMetrX 4.0 is expected to be rolled out internally in the fourth quarter of 2025, with commercialization for new and existing customer deployments planned for the first half of 2026. The software aims to streamline data analytics for physicians, MSOs, 340B entities, and pharmacies.
The integration of AI-powered enhancements is designed to increase the software's value as a comprehensive decision-support system, enabling more streamlined collection, analysis, and operationalization of healthcare data. The global AI in healthcare market was estimated at $26.57 billion in 2024 and is projected to reach $187.69 billion by 2030, indicating a significant growth opportunity.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.